These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1413803)

  • 1. [Allergic reactions to teniposide (VM-26) in children with neoplasms].
    Wysocki M; Nowaczyk-Michalak A; Pilecki O
    Wiad Lek; 1992 Feb; 45(3-4):91-3. PubMed ID: 1413803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergic reactions to teniposide in patients with neuroblastoma and lymphoid malignancies.
    Hayes FA; Abromowitch M; Green AA
    Cancer Treat Rep; 1985 Apr; 69(4):439-41. PubMed ID: 3857970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
    Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
    Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypersensitivity reactions to epipodophyllotoxins in children with acute lymphoblastic leukemia.
    Kellie SJ; Crist WM; Pui CH; Crone ME; Fairclough DL; Rodman JH; Rivera GK
    Cancer; 1991 Feb; 67(4):1070-5. PubMed ID: 1991254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monitoring of methotrexate treatment of children with proliferative diseases of the hematopoietic system].
    Bogusławska-Jaworska J; Orzechowska-Juzwenko K; Pejcz J; Wiela-Hojeńska A; Szczepaniak M; Erbel-Badeńska J
    Pol Tyg Lek; 1988 Aug; 43(33):1053-6. PubMed ID: 3266666
    [No Abstract]   [Full Text] [Related]  

  • 6. Teniposide for acute lymphoblastic leukemia.
    Med Lett Drugs Ther; 1992 Nov; 34(883):105-6. PubMed ID: 1435505
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypersensitivity to VM-26].
    Köster B; Ritter J; Bode U
    Klin Padiatr; 1984; 196(3):178-80. PubMed ID: 6540829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytosine arabinoside and VM-26 in induction treatment, failures and recurrences of childhood acute lymphoblastic leukemias].
    Navajas Gutiérrez A; Bezanilla Regato JL; Moya Calderón E; Piñán MA
    An Esp Pediatr; 1988 Oct; 29 Suppl 34():91-3. PubMed ID: 3214046
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytogenetic and molecular analysis of MLL rearrangements in acute lymphoblastic leukaemia survivors.
    Brassesco MS; Montaldi AP; Gras DE; Camparoto ML; Martinez-Rossi NM; Scrideli CA; Tone LG; Sakamoto-Hojo ET
    Mutagenesis; 2009 Mar; 24(2):153-60. PubMed ID: 19028982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Philadelphia chromosome-positive acute lymphoblastic leukemia after therapy for Langerhans cell histiocytosis.
    Tatsumi T; Shimazaki C; Araki SI; Sudo Y; Yamagata N; Ashihara E; Goto H; Inaba T; Fujita N; Nakagawa M; Misawa SI; Imashuku S
    Am J Hematol; 1997 Jan; 54(1):88. PubMed ID: 8980271
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical trials of teniposide (VM-26) in childhood acute lymphocytic leukemia.
    Rivera GK; Evans WE
    Semin Oncol; 1992 Apr; 19(2 Suppl 6):51-8. PubMed ID: 1411639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia.
    Zalewska-Szewczyk B; Andrzejewski W; Bodalski J
    Pediatr Blood Cancer; 2004 Oct; 43(5):600-2. PubMed ID: 15382279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypersensitivity reactions to teniposide in children.
    Carstensen H; Nolte H; Hertz H; Jensen T
    J Clin Oncol; 1987 Sep; 5(9):1491-2. PubMed ID: 3625264
    [No Abstract]   [Full Text] [Related]  

  • 14. [Allergic reactions in treatment with L-asparaginase. Significance of specific IgE antibodies].
    Körholz D; Wahn U; Jürgens H; Wahn V
    Monatsschr Kinderheilkd; 1990 Jan; 138(1):23-5. PubMed ID: 2314401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia.
    Yang L; Panetta JC; Cai X; Yang W; Pei D; Cheng C; Kornegay N; Pui CH; Relling MV
    J Clin Oncol; 2008 Apr; 26(12):1932-9. PubMed ID: 18421047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperglycemia, ketoacidosis and other complications of L-asparaginase in children with acute lymphoblastic leukemia.
    Cetin M; Yetgin S; Kara A; Tuncer AM; Günay M; Gümrük F; Gürgey A
    J Med; 1994; 25(3-4):219-29. PubMed ID: 7996065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VM-26 (teniposide)-induced hypersensitivity and degranulation of basophils in children.
    Nolte H; Carstensen H; Hertz H
    Am J Pediatr Hematol Oncol; 1988; 10(4):308-12. PubMed ID: 2467573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypersensitivity reactions to teniposide (VM-26): an analysis.
    O'Dwyer PJ; King SA; Fortner CL; Leyland-Jones B
    J Clin Oncol; 1986 Aug; 4(8):1262-9. PubMed ID: 3525769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in teniposide plasma protein binding is correlated with serum albumin concentrations.
    Petros WP; Rodman JH; Relling MV; Christensen M; Pui CH; Rivera GK; Evans WE
    Pharmacotherapy; 1992; 12(4):273-7. PubMed ID: 1518726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute nonlymphoblastic leukemia in children treated for acute lymphoblastic leukemia with an intensive regimen including teniposide.
    Verdeguer A; Ruiz JG; Ferris J; Esquembre C; Tasso MJ; Fernandez JM; Prieto F; Castel V
    Med Pediatr Oncol; 1992; 20(1):48-52. PubMed ID: 1727211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.